BSE Live
Mar 02, 16:01Prev. Close
8842.60
Open Price
8399.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 02, 15:59Prev. Close
8849.00
Open Price
8352.00
Bid Price (Qty.)
8801.00 (10)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of AstraZeneca Pharma (in Rs. Cr.) | Dec 09 | Dec 08 | Dec 07 | Dec 06 | Dec 05 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 23.05 | 29.53 | 24.58 | 19.49 | 86.12 | |
| Diluted EPS (Rs.) | 23.05 | 29.53 | 24.58 | 19.49 | 86.12 | |
| Cash EPS (Rs.) | 25.48 | 32.28 | 26.92 | 21.79 | 96.51 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 57.81 | 46.46 | 63.72 | 56.69 | 254.39 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 57.81 | 46.46 | 63.72 | 56.69 | 254.39 | |
| Dividend / Share(Rs.) | 10.00 | 15.00 | 15.00 | 12.00 | 20.00 | |
| Revenue from Operations/Share (Rs.) | 158.89 | 142.53 | 121.23 | 107.52 | 451.30 | |
| PBDIT/Share (Rs.) | 37.84 | 50.45 | 40.48 | 32.27 | 140.05 | |
| PBIT/Share (Rs.) | 35.41 | 47.70 | 38.14 | 29.98 | 129.66 | |
| PBT/Share (Rs.) | 35.36 | 45.75 | 38.14 | 29.98 | 129.55 | |
| Net Profit/Share (Rs.) | 23.05 | 29.53 | 24.58 | 19.49 | 86.12 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 23.81 | 35.39 | 33.38 | 30.01 | 31.03 | |
| PBIT Margin (%) | 22.28 | 33.46 | 31.46 | 27.88 | 28.73 | |
| PBT Margin (%) | 22.25 | 32.09 | 31.46 | 27.88 | 28.70 | |
| Net Profit Margin (%) | 14.50 | 20.72 | 20.27 | 18.13 | 19.08 | |
| Return on Networth / Equity (%) | 39.86 | 63.56 | 38.57 | 34.38 | 33.85 | |
| Return on Capital Employed (%) | 39.31 | 40.75 | 37.82 | 33.62 | 32.98 | |
| Return on Assets (%) | 24.42 | 25.39 | 24.64 | 20.05 | 24.08 | |
| Total Debt/Equity (X) | 0.00 | 0.54 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 168.37 | 122.54 | 121.52 | 110.59 | 126.20 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.24 | 2.33 | 2.43 | 2.10 | 2.96 | |
| Quick Ratio (X) | 1.85 | 2.02 | 2.16 | 1.75 | 2.44 | |
| Inventory Turnover Ratio (X) | 11.29 | 10.48 | 12.74 | 7.90 | 8.98 | |
| Dividend Payout Ratio (NP) (%) | 43.38 | 50.78 | 61.01 | 61.55 | 23.22 | |
| Dividend Payout Ratio (CP) (%) | 39.25 | 46.46 | 55.72 | 55.07 | 20.72 | |
| Earnings Retention Ratio (%) | 56.62 | 49.22 | 38.99 | 38.45 | 76.78 | |
| Cash Earnings Retention Ratio (%) | 60.75 | 53.54 | 44.28 | 44.93 | 79.28 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 2,304.76 | 1,153.82 | 1,524.96 | 1,383.25 | 1,208.00 | |
| EV/Net Operating Revenue (X) | 5.80 | 3.24 | 5.03 | 5.15 | 5.35 | |
| EV/EBITDA (X) | 24.36 | 9.15 | 15.07 | 17.14 | 17.25 | |
| MarketCap/Net Operating Revenue (X) | 5.97 | 3.47 | 5.40 | 5.55 | 5.65 | |
| Retention Ratios (%) | 56.61 | 49.21 | 38.98 | 38.44 | 76.77 | |
| Price/BV (X) | 16.42 | 10.63 | 10.27 | 10.52 | 10.03 | |
| Price/Net Operating Revenue | 5.97 | 3.47 | 5.40 | 5.55 | 5.65 | |
| Earnings Yield | 0.02 | 0.06 | 0.04 | 0.03 | 0.03 |
12.02.2026
01.02.2026
12.11.2025
AstraZeneca Standalone September 2025 Net Sales at Rs 559.09 crore, up 37.03% Y-o-Y
10.11.2025
12.11.2025
AstraZeneca Standalone September 2025 Net Sales at Rs 559.09 crore, up 37.03% Y-o-Y
06.06.2025
AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y
17.02.2025
AstraZeneca Standalone December 2024 Net Sales at Rs 440.29 crore, up 43.98% Y-o-Y
21.11.2024
AstraZeneca Standalone September 2024 Net Sales at Rs 408.00 crore, up 31.16% Y-o-Y